dc.description.abstract |
This research, focused on developing a coating on biodegradable polymer sutures to improve
their antibacterial and wound healing properties. The coating consisted of curcumin, zinc
oxide nanoparticles (ZnO), and polyethylene glycol (PEG) with varying curcumin
concentrations of 5%, 10%, 15%, and 20%. The synthesis of the coating was determined via
various characterization techniques: Scanning Electron Microscopy (SEM), Fourier
Transform Infrared (FTIR) Spectroscopy, X-ray diffraction (XRD). The antibacterial efficacy
of the coated sutures was evaluated against Escherichia coli (E. coli), Staphylococcus aureus
(S. aureus), Klebseilla pneumoniae (K. pneumoniae), and Enterococcus faecium (E. faecium),
with the 20% curcumin composite demonstrating the largest zones of inhibition. Hemolysis
testing indicated that the 20% curcumin composite exhibited the highest hemolysis
percentage at 1%, which is within the acceptable range for biomedical applications.
Mechanical testing revealed an enhancement in the breaking force of the coated sutures,
increasing from 22N for uncoated sutures to 26N for the coated ones. Drug release studies
indicated an initial burst release within the first 24 hours, followed by a sustained release over
time. In addition, in vitro cytocompatibility tests were performed to confirm the
biocompatibility of the treated sutures. The assays included determination of cell viability,
proliferation. These findings suggest that the 20% curcumin-ZnO NPs-PEG composite
coating significantly enhances the antimicrobial properties, mechanical strength, and drug
release profile of surgical sutures, making them a promising candidate for preventing surgical
site infections. . In addition, in vivo experiments demonstrated accelerated wound healing in
intestinal anastomosis models followed by histology with H&E staining, implies improved
tissue remodeling and decreased inflammation. 20% Curcumin/ZnO NPs/PEG composite
coating had best antibacterial effect, biocompatibility and wound healing efficacy, which
potentially can set as a future suture for decreasing SSIs and for intestinal anastomotic
healing. |
en_US |